Neuroendocrine tumors of the duodenum and pancreas;Neuroendokrine Tumoren des Duodenums und Pankreas

Chirurg

Volumn 82, Issue 7, 2011, Pages 583-590

  Fischer, L ^a   Mehrabi, A ^a   Buchler M W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carcinoma; Duodenum; Neuroendocrine tumors; Operative therapy; Pancreas

Indexed keywords

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COOPERATION; DUODENUM TUMOR; ENDOSCOPIC ECHOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERDISCIPLINARY COMMUNICATION; LIVER TRANSPLANTATION; LIVER TUMOR; METASTASIS; NEUROENDOCRINE TUMOR; PALLIATIVE THERAPY; PANCREAS TUMOR; PATHOLOGY; PATIENT CARE; PROGNOSIS;

COOPERATIVE BEHAVIOR; DUODENAL NEOPLASMS; ENDOSCOPY, GASTROINTESTINAL; ENDOSONOGRAPHY; HUMANS; INTERDISCIPLINARY COMMUNICATION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PATIENT CARE TEAM; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959967953     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-011-2069-9     Document Type: Article

References (69)

1. Scherubl H, Schwertner C, Steinberg J et al (2010) Neuroendocrine tumors of the small bowels are on the rise: early tumors and their management. Z Gastroenterol 48: 406-413.
2. Schimmack S, Svejda B, Lawrence B et al (2011) The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbecks Arch Surg 396: 273-298.
3. Modlin IM, Champaneria MC, Chan AK, Kidd M (2007) A three-decade analysis of 3, 911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 102: 1464-1473.
4. Modlin IM, Oberg K, Chung DC et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9: 61-72.
5. Ito T, Tanaka M, Sasano H et al (2007) Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors. J Gastroenterol 42: 497-500.
6. Hauso O, Gustafsson BI, Kidd M et al (2008) Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 113: 2655-2664.
7. Hassan MM, Phan A, Li D et al (2008) Risk factors associated with neuroendocrine tumors: A U. S.-based case-control study. Int J Cancer 123: 867-873.
8. Fuchs M, Schepp W (2008) Importance of endoscopy and endosonography for chronic pancreatitis and benign pancreas tumors. Radiologe 48: 721-724; 6-31.
9. Grenacher L, Klauss M (2009) Computed tomography of pancreatic tumors. Radiologe 49: 107-123.
10. Grenacher L, Klauss M, Dukic L et al (2004) Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT - a prospective study. Rofo 176: 1624-1633.
11. Zerbi A, Capitanio V, Boninsegna L et al (2011) Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases. Langenbecks Arch Surg 396: 313-321.
12. Eriksson B, Kloppel G, Krenning E et al (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87: 8-19.
13. Pape UF, Bohmig M, Berndt U et al (2004) Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a German referral center. Ann NY Acad Sci 1014: 222-233.
14. Vagefi PA, Razo O, Deshpande V et al (2007) Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg 142: 347-354.
15. O'Toole D, Salazar R, Falconi M et al (2006) Rare functioning pancreatic endocrine tumors. Neuroendocrinology 84: 189-195.
16. Kouvaraki MA, Shapiro SE, Cote GJ et al (2006) Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 30: 643-653.
17. Fischer L, Kleeff J, Esposito I et al (2008) Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 95: 627-635.
18. Jensen RT, Rindi G, Arnold R et al (2006) Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 84: 165-172.
19. Jensen RT, Niederle B, Mitry E et al (2006) Gastrinoma (duodenal and pancreatic). Neuroendocrinology 84: 173-182.
20. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13, 715 carcinoid tumors. Cancer 97: 934-959.
21. Strosberg J, Gardner N, Kvols L (2009) Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut. Neuroendocrinology 89: 471-476.
22. Kloppel G, Rindi G, Perren A et al (2010) The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment. Pathologe 31: 353-354.
23. Scarpa A, Mantovani W, Capelli P et al (2010) Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 23: 824-833.
24. Rindi G, Kloppel G, Couvelard A et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451: 757-762.
25. Oberg K (2010) Pancreatic endocrine tumors. Semin Oncol 37: 594-618.
26. Casadei R, Ricci C, Pezzilli R et al (2009) Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. World J Surg 33: 2458-2463.
27. Kloppel G, Rindi G, Perren A et al (2010) The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 456: 595-597.
28. Mortellaro VE, Hochwald SN, McGuigan JE et al (2009) Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1. Am Surg 75: 730-733.
29. Hartel M, Wente MN, Sido B et al (2005) Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol 20: 676-681.
30. Jagadheesan V, Suresh SS (2008) Episodic confusional state: due to insulinoma. Indian J Psychiatry 50: 197-199.
31. Tiling N, Ricke J, Wiedenmann B (2002) Neuroendocrine tumors of the gastrointestinal-pancreatic system. Classification and diagnosis. Internist 43: 210-218.
32. Imamura M (2010) Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J Gastroenterol 16: 4519-4525.
33. Fendrich V, Langer P, Waldmann J et al (2007) Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg 94: 1331-1341.
34. Grant CS, Charboneau JW, Reading CC et al (1988) Insulinoma: the value of intraoperative ultrasonography. Wien Klin Wochenschr 100: 376-380.
35. Anlauf M, Perren A, Kloppel G (2007) Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance. Pathobiology 74: 279-284.
36. Zhuang Z, Vortmeyer AO, Pack S et al (1997) Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57: 4682-4686.
37. Marx SJ, Simonds WF (2005) Hereditary hormone excess: genes, molecular pathways, and syndromes. Endocr Rev 26: 615-661.
38. Anlauf M, Schlenger R, Perren A et al (2006) Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol 30: 560-574.
39. Doherty GM, Olson JA, Frisella MM et al (1998) Lethality of multiple endocrine neoplasia type I. World J Surg 22: 581-586; discussion 586-587.
40. Yao JC, Shah MH, Ito T et al (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364: 514-523.
41. Fendrich V, Bartsch DK (2011) Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg 396: 299-311.
42. Norton JA, Fraker DL, Alexander HR et al (2006) Surgery increases survival in patients with gastrinoma. Ann Surg 244: 410-419.
43. Plockinger U, Rindi G, Arnold R et al (2004) Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80: 394-424.
44. Olausson M, Friman S, Herlenius G et al (2007) Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl 13: 327-333.
45. Steinmuller T, Kianmanesh R, Falconi M et al (2008) Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 87: 47-62.
46. Kooby DA, Gillespie T, Bentrem D et al (2008) Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 248: 438-446.
47. Kendrick ML, Cusati D (2010) Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience. Arch Surg 145: 19-23.
48. Gagner M, Palermo M (2009) Laparoscopic Whipple procedure: review of the literature. J Hepatobiliary Pancreat Surg 16: 726-730.
49. Addeo P, Giulianotti PC (2010) Update on laparoscopic pancreatectomy in 2010. Minerva Chir 65: 655-666.
50. Fernandez-Cruz L, Blanco L, Cosa R, Rendon H (2008) Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg 32: 904-917.
51. Merchant NB, Parikh AA, Kooby DA (2009) Should all distal pancreatectomies be performed laparoscopically? Adv Surg 43: 283-300.
52. Horiguchi A, Uyama I, Miyakawa S (2011) Robot-assisted laparoscopic pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 18: 287-291.
53. Kiely JM, Nakeeb A, Komorowski RA et al (2003) Cystic pancreatic neoplasms: enucleate or resect? J Gastrointest Surg 7: 890-897.
54. Norton JA, Fraker DL, Alexander HR et al (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341: 635-644.
55. Gauger PG, Doherty GM, Broome JT et al (2009) Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms. Surgery 146: 801-806; discussion 807-808.
56. Goudet P, Murat A, Binquet C et al (2010) Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 34: 249-255.
57. Pfeifer AK, Gregersen T, Gronbaek H et al (2011) Peptide receptor radionuclide therapy with (90)Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tTumors: Results from a Danish cohort treated in Switzerland. Neuroendocrinology (in press).
58. Auernhammer CJ, Goke B (2011) Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin. Gut (Epub ahead of print).
59. Bonaccorsi-Riani E, Apestegui C, Jouret-Mourin A et al (2010) Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review. Transpl Int 23: 668-678.
60. Shimizu N, Kaminishi M (2008) Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum. Nippon Geka Gakkai Zasshi 109: 147-151.
61. Stoeltzing O, Loss M, Huber E et al (2010) Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Langenbecks Arch Surg 395: 185-192.
62. De Angelis C, Carucci P, Repici A, Rizzetto M (1999) Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound 10: 139-150.
63. Seo DW (2010) EUS-guided antitumor therapy for pancreatic tumors. Gut Liver 4 (Suppl 1): S76-S81.
64. Nikou GC, Toubanakis C, Moulakakis KG et al (2011) Carcinoid tumors of the duodenum and the ampulla of Vater: current diagnostic and therapeutic approach in a series of 8 patients. Case series. Int J Surg (in press).
65. Kahaleh M, Shami VM, Brock A et al (2004) Factors predictive of malignancy and endoscopic resectability in ampullary neoplasia. Am J Gastroenterol 99: 2335-2339.
66. Scherubl H, Faiss S, Tschope R, Zeitz M (2005) Double-balloon enteroscopy for the detection of midgut carcinoids. Gastrointest Endosc 62: 994; author's reply 995.
67. Karagiannis S, Eshagzaiy K, Duecker C et al (2009) Endoscopic resection with the cap technique of a carcinoid tumor in the duodenal bulb. Endoscopy 41 (Suppl 2): E288-289.
68. Rindi G, Kloppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449: 395-401.
69. Anlauf M, Sipos B, Kloppel G (2005) Tumors of the endocrine pancreas. Pathologe 26: 46-51.